IL-25 improves diabetic wound healing through stimulating M2 macrophage polarization and fibroblast activation
- 8 February 2022
- journal article
- research article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 106, 108605
- https://doi.org/10.1016/j.intimp.2022.108605
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Interleukin (IL)‐25: Pleiotropic roles in asthmaRespirology, 2015
- Matrix remodeling by MMPs during wound repairMatrix Biology, 2015
- Characteristics of IL‐25 and allergen‐induced airway fibrosis in a murine model of asthmaRespirology, 2015
- Targeting Inflammatory Cytokines and Extracellular Matrix Composition to Promote Wound RegenerationAdvances in Wound Care, 2014
- IL-25 Downregulates Th1/Th17 Immune Response in an IL-10–Dependent Manner in Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2013
- T Cell-Derived Act1 Is Necessary for IL-25–Mediated Th2 Responses and Allergic Airway InflammationThe Journal of Immunology, 2011
- IL-25 Induces M2 Macrophages and Reduces Renal Injury in Proteinuric Kidney DiseaseJournal of the American Society of Nephrology, 2011
- Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase–dependent induction of Socs-3Blood, 2009
- Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD MiceDiabetes, 2009
- Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tractThe Journal of Experimental Medicine, 2006